AstraZeneca Sues to Overturn New Mexico 340B Drug Discount Law

Jan. 19, 2026, 5:38 PM UTC

A New Mexico state law imposing restraints on a drug discount program violates federal law, AstraZeneca Pharmaceuticals LP said in a complaint filed in federal court in New Mexico.

The drugmaker sued New Mexico Attorney General Raul Torrez and members of the state’s Board of Pharmacy in the US District Court for the District of New Mexico on Jan. 16, arguing the state cannot require it to offer discounted drugs to an unlimited number of pharmacies contracting with federally qualified health centers.

AstraZeneca’s lawsuit is the latest in a string of legal challenges to state laws around the 340B drug ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.